Pro: Treasury, IRS seem to be targeting AGN-PFE deal

3:08 PM ET Tue, 5 April 2016

CNBC's Meg Tirrell and Ipsita Smolinski, Managing Director and Health Care Analyst at Capitol Street, discuss the implications for the Allergan/Pfizer deal and other multinational companies with the new tax inversion rules from the Treasury Department.